Acid Reflux/GERD News

Sensory Treatment Reduces Autistic Mannerisms

Mon, 23 Jun 2008 07:20:04 GMT

Parents of children with autism are increasingly turning to sensory integration treatment to help their children deal with the disorder, and they're seeing good results.

Full text

VYVANSE Demonstrated Significant Improvement In ADHD Symptoms In Adults

Mon, 23 Jun 2008 07:20:03 GMT

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, presented the results of a phase III pivotal study in which VYVANSE demonstrated significant improvements in Attention Deficit Hyperactivity Disorder (ADHD) symptoms in adults and met all safety and efficacy endpoints.

Full text

FDA Approves Strattera R For Maintenance Of ADHD In Children And Adolescents

Mon, 23 Jun 2008 07:20:03 GMT

Eli Lilly and Company (NYSE: LLY) announced that the United States Food and Drug Administration (FDA) has approved Strattera(R) (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.

Full text

Researcher Reports On Noninvasive Device For GERD, Obesity

Mon, 23 Jun 2008 07:00:06 GMT

A new, noninvasive gastroplasty device to treat two separate disorders gastroesophageal-reflux disease (GERD) and morbid obesity was reported by its inventor, Charles J.

Full text

MGH Study Confirms Benefit Of Surgery For Gastroesophageal Reflux

Mon, 23 Jun 2008 07:00:05 GMT

Despite the growing availability of prescription and over-the-counter medications for gastroesophageal reflux disease (GERD), surgical treatment remains a viable alternative for patients whose symptoms persist.

Full text

The Features Of Chinese Patients With Reflux Esophagitis

Mon, 23 Jun 2008 07:00:04 GMT

Gastroesophageal reflux disease (GERD) is described as the chronic symptoms and/or tissue damage caused by the reflux of abnormal gastric contents to the esophagus.

Full text

TAK-390MR Phase 3 Data Presented At Digestive Disease Week

Mon, 23 Jun 2008 07:00:04 GMT

TAP Pharmaceutical Products Inc. have reported results from three pivotal Phase 3 studies evaluating investigational new drug TAK-390MR, the first proton pump inhibitor (PPI) with an innovative dual delayed release technology, in healing patients with erosive esophagitis (EE) and in maintenance of healed EE.

Full text

Simplicity Of Working Memory Study Could Help With ADD And Other Attention Difficulties

Sun, 22 Jun 2008 04:00:07 GMT

A mind is a terrible thing to waste, but humans may have even less to work with than previously thought.

Full text

OROS R Methylphenidate In Adults With ADHD: New Insights

Sun, 22 Jun 2008 04:00:06 GMT

Although once considered to be a disorder only seen in children, Attention Deficit Hyperactivity Disorder (ADHD) is now known to be a condition associated with a wide range of functional impairments throughout the lifespan(1).

Full text

New Analysis In Boys And Girls Shows The ADHD Patch, DAYTRANA TM methylphenidate Transdermal System , Offered ADHD Symptom Control For 12 Months

Sun, 22 Jun 2008 04:00:06 GMT

Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRANA(TM) (methylphenidate transdermal system) between boys and girls aged 6 to 12 years with Attention Deficit Hyperactivity Disorder (ADHD).

Full text